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A B S T R A C T
Background: Ionizing radiation remains a well-known risk factor of carotid artery stenosis. The sur-
vival rates of head and neck cancer patients undergoing radiotherapy have risen owing to medical 
advancements in the field. As a consequence, the incidence of carotid artery stenosis in these high-risk 
patients has increased. 
Aims: In this study we sought to compare the outcomes of carotid endarterectomy (CEA) vs carotid 
artery stenting (CAS) for radiation-induced carotid artery stenosis.
Methods: This study was performed according to the Preferred Reporting Items for Systematic reviews 
and Meta-Analyses guidelines. Eligible studies were identified through a comprehensive search of 
PubMed, Scopus and Cochrane Central until July 2020. A random-effects model meta-analysis was con-
ducted, and odds ratios (ORs) were calculated. The I-square statistic was used to assess for heterogeneity.
Results: Seven studies and 201 patients were included. Periprocedural stroke, myocardial infarction 
(MI), and death rates were similar between the two revascularization approaches. However, the risk for 
cranial nerve (CN) injury was higher in the CEA group (OR, 7.40; 95% CI, 1.58–34.59; I2 = 0%). Analysis 
revealed no significant difference in terms of long-term mortality (OR, 0.41; 95% CI, 0.14–1.16; I2 = 0%) 
and restenosis rates (OR, 0.69; 95% CI, 0.29–1.66; I2 = 0%) between CEA and CAS after a mean follow-up 
of 40.5 months.
Conclusions: CAS and CEA appear to have a similar safety and efficacy profile in patients with radia-
tion-induced carotid artery stenosis. Patients treated with CEA have a higher risk for periprocedural CN 
injuries. Future prospective studies are warranted to validate these results.
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INTRODUCTION
Carotid artery stenting (CAS) is a less invasive alternative 
approach to carotid endarterectomy (CEA) [1]. Currently, 
CEA remains the gold standard for treatment of both symp-
tomatic and asymptomatic carotid atherosclerotic disease, 
whereas CAS is currently reserved for patients with high 
surgical risk, including those with post-radiation stenosis 
[2–5]. Proposed mechanisms for post-radiation carotid ste-
nosis include de novo atherosclerotic lesion development 
or progression of existing plaques [6, 7]. These atherogenic 
properties of ionizing radiation have been attributed to 
pro-inflammatory reactions within the arterial wall that 
weaken endothelial cells barrier, leading to inflammatory 
cell recruitment, accumulation and eventually plaque 
formation [8, 9]. 
Significant carotid stenosis can cause devastating 
neurological complications, including disabling stroke and 
transient ischemic attacks (TIA) [9]. Considering the increas-
ing survival rates of patients who undergo radiotherapy for 
head and neck cancer, the incidence of radiation induced 
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W H A T ’ S  N E W ? 
Radiation-induced carotid stenosis is associated with an increased stroke risk and it is a challenging clinical entity. Carotid 
endarterectomy (CEA) and carotid artery stenting (CAS) are the two revascularization approaches. Prior work suggested that 
performing CEA in patients with radiation-induced carotid stenosis might be associated with a lower long-term mortality. 
The present study, including larger population, did not identify a statistically significant difference in the odds of long-term 
mortality between patients treated with CEA vs CAS, and confirmed a higher rate of cranial nerve injury with CEA. In addition, 
we now provide a subgroup analysis based on embolic protection device utilization along with suggestions for the design of 
future studies. 
carotid artery stenosis has risen [10]. The time period from 
radiation exposure to the development of atherosclerotic 
carotid lesions causing significant stenosis varies across 
the literature [6, 11], with a recent systematic review sug-
gesting that the yearly incidence of carotid stenosis >50% 
increases every year during the first three years after radi-
ation treatment [12]. Interestingly, patients who received 
radiotherapy for head and neck malignancies are at higher 
risk for TIAs or strokes compared to patients with carotid 
stenosis who were not exposed to radiation therapy [13]. 
However, the optimal revascularization approach for 
this high-risk population is still debatable. CEA can be 
challenging to perform in patients with a history of radia-
tion exposure in the neck due to extensive tissue scarring, 
whereas CAS has been related to poor long-term anatomic 
outcome and higher restenosis rates [13–15]. The aim of 
this systematic review and meta-analysis was to compare 
the safety and efficacy profiles of CEA and CAS for treat-
ment of radiation-induced carotid stenosis.
METHODS
This systematic review and meta-analysis was performed 
according to the Preferred Reporting Items for Systematic 
reviews and Meta-Analyses (PRISMA) guidelines [16]. Liter-
ature searches were systematically conducted in PubMed, 
Scopus, and Cochrane Central by two independent inves-
tigators. The following algorithm was utilized for PubMed 
dataset: (“radiotherapy” OR “irradiation” OR “radiation”) 
AND (“cervical” OR “neck”) AND “carotid” AND (“stenosis” OR 
“atherosclerosis” OR “restenosis”) AND (“operation” OR “sur-
gery” OR “surgical” OR “endarterectomy”) AND (“stent” OR 
“stenting” OR “angioplasty” OR “balloon” OR “endovascular” 
OR “percutaneous”). Any disagreements were resolved with 
discussion and consensus was settled with the addition 
of a 3rd independent reviewer. Additionally, the references 
of the eligible articles were manually reviewed in order to 
identify potential additional studies.
Studies that fulfilled all the predefined inclusion criteria 
were eventually included in this meta-analysis. These were: 
(1) randomized controlled trials (RCT) or observational 
studies comparing CEA vs CAS for radiation-induced carotid 
stenosis; (2) studies reporting on relevant clinical outcomes 
(e.g. restenosis rate, death, stroke, transient ischemic attack, 
myocardial infarction, cranial nerve injury); (3) studies 
published up to July 2020. For this systematic review and 
meta-analysis of study level data no approval by a local 
institutional review board was required.
Data extraction and risk of bias assessment
Data extraction was performed by 2 independent inves-
tigators (AT, DX), blind to each other. All disagreements 
were discussed with a 3rd reviewer (SG) until consensus 
was settled. The incidence of stroke within 30 days was the 
primary endpoint. Secondary endpoints were TIA, cranial 
nerve (CN) injuries, myocardial infarction (MI) and death 
within 30 days, and long-term mortality and carotid artery 
restenosis. Risk of bias was assessed by 2 investigators with 
the Robins-I tool for non-randomized studies [17]. Addi-
tionally, publication bias was evaluated with the methods 
of the Egger’s test and funnel plots.
Statistical synthesis and analysis
Odds ratios (ORs) with the corresponding 95% confidence 
intervals (CIs) were synthesized for the primary and sec-
ondary outcomes. A random-effects model was used to 
evaluate heterogeneity among studies with the Higgins 
I-square (I2) statistic [18]. I2 greater than 75% indicated 
significant heterogeneity [18]. The main results (i.e. effect 
size of each study and pooled estimates) were graphically 
displayed with a forest plot. A P-value <0.05 was consid-
ered significant. The statistical software used was STATA 
14.1 (StataCorp, College Station, TX, USA). 
RESULTS
Search results
Literature search yielded 191 potentially eligible records 
after duplicates were removed. Fifteen articles were re-
trieved for full-text evaluation after screening titles and 
abstracts. Overall, 7 comparative studies satisfied the 
predetermined search criteria and were included in this 
meta-analysis [19–25]. The PRISMA flow diagram is illus-
trated in Figure 1.
Characteristics of the studies and patients
In total, 201 patients undergoing procedures for radiation 
induced carotid artery stenosis were included in this study 
(CEA, 50.2% [n = 101/201] vs CAS, 49.8% [n = 100/201]). The 
mean weighted long-term follow up was 40.5 months as 
calculated from studies with available data. The average 
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Figure 1. Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) flow diagram
Table 1. Important patient characteristics
Study Country Total 
number of 
patients, n











Carpenter 2018 [22] USA 12 3 9 59.6 NR 0 0 0





Massoni 2017 [23] Italy 12 5 7 71 75 17 0 28
Sano 2015 [19] Japan 21 11 10 71.6 95 59 NR NR
Dorth 2014 [21] USA 9 3 6 56 78 0 0 0
Tallarita 2011 [20] USA 60 27 33 66.5 75 65 74 57
Hassen-Kohdja 2004 [25] International 44 31 13 64.4 51 80 NR NR
Abbreviations: CAS, carotid artery stenting; CEA, carotid endarterectomy; NR, not reported
time interval between carotid artery irradiation and carotid 
intervention among the individual studies is presented in 
Supplementary material, Figure S1. No studies with high 
risk of bias were identified. A detailed assessment of risk 
of bias can be found in Supplementary material, Table 
S1. Overall, 19.7% (n = 34/173) of the patients had diabetes, 
25.4% (n = 44/173) had CAD, and 45.5% (n = 80/176) had 
a type of dyslipidemia. Important patient characteristics are 
summarized in Table 1, while details about comorbidities 
in the CEA and CAS group are presented in Supplementary 
material, Table S2.
Carotid artery duplex ultrasound was the most com-
monly used imaging study to evaluate the plaques’ compo-
sition and the degree of stenosis. Additionally, computed 
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tomography angiography or magnetic resonance angi-
ography were performed or reviewed pre-procedurally 
in order to identify more specific lesion characteristics, 
including but not limited to lesion length, degree of cal-
cification, existence of thrombus, or ulceration. The most 
commonly utilized stents were bare metal stents includ-
ing the PRECISE stent (Cordis [43.4%; n = 33/76]) and the 
Wallstent (Boston Scientific [51.3%; n = 39/76]). Carotid 
artery stenting was mainly performed through femoral 
access and with local anesthesia. An embolic protection 
device (EDP) was utilized in 81.6% (n = 62/76) of the CAS 
cases. This lower than expected percentage of EPD utiliza-
tion was largely driven by the study by Tallarita et al. [20], 
which reported a 67.5% EPD utilization rate (n = 25/37). 
Three studies [21, 22, 25] did not report their EPD utiliza-
tion rate while the rest reported >90% utilization. 
Early periprocedural outcomes (within 30 days)
The two carotid revascularization techniques were 
comparable in terms of periprocedural stroke (CEA, 1.4%; 
n = 1/71 vs CAS, 3.4%; n = 2/58; OR, 0.64; 95% CI, 0.12–3.37; 
I2 = 0%) (Figure 2). Of note, the study by Tallarita et al. [20] 
was not used in the analysis of stroke because of an EPD 
utilization rate that does not correspond to the current 
standard of care. In addition, no differences in terms of 
death (CEA, 1.9%; n = 2/101 vs CAS, 0%; n = 0/100; OR, 
1.54; 95% CI, 0.34–6.91; I2 = 0%) (Figure 3) and myocardial 
infarction (CEA, 4.6%; n = 2/43 vs CAS, 0%; n = 0/50; OR, 2.36; 
95% CI, 0.30–18.60; I2 = 0%) (Figure 4) were identified. How-
ever, patients undergoing CEA had a significantly higher 
incidence of CN injuries compared to patients undergoing 
CAS (CEA, 17.1%; n = 11/64 vs CAS, 0%; n = 0/72; OR, 7.40; 
95% CI, 1.58–34.59; I2 = 0%) (Figure 5). The most common 
Figure 2. Comparison of 30-day stroke 
between carotid endarterectomy (CEA) and 
carotid artery stenting (CAS)
Figure 3. Comparison of 30-day mortality 
between carotid endarterectomy (CEA) and 
carotid artery stenting (CAS)
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Figure 4. Comparison of 30-day myocardial 
infarction between carotid endarterectomy 
(CEA) and carotid artery stenting (CAS)
Figure 5. Comparison of cranial nerve injuries 
between carotid endarterectomy (CEA) and 
carotid artery stenting (CAS)
injuries affected the hypoglossal and vagus nerves. Two CN 
injuries were reported to cause permanent deficits. There 
was no obvious asymmetry in the funnel plots of all early 
periprocedural outcomes, which were validated by nonsig-
nificant results following the Egger’s test (stroke: P = 0.10; 
MI: P = 0.06; death: P = 0.06; CNI: P = 0.07) (Supplementary 
material, Figure S2).
Late outcomes 
Long-term all-cause mortality (40.5 months average) 
was similar between the CEA and CAS groups (CEA, 
7.1%; n = 5/70 vs CAS, 17.2%; n = 15/87; OR, 0.41; 95% CI, 
0.14–1.16; I2 = 0%) (Figure 6). Similarly, no difference was de-
tected in the incidence of carotid artery restenosis among 
patients undergoing CEA vs CAS (CEA, 10.9%; n = 10/101 vs 
CAS, 17%; n = 17/100; OR, 0.69; 95% CI, 0.29–1.66; I2 = 0%) 
(Figure 7). No evidence of publication bias was found for 
long-term outcomes based on the Egger’s test (long-term 
all-cause mortality: P = 0.14; restenosis: P = 0.53) and funnel 
plots (Supplementary material, Figure S2).
Subgroup analysis
A subgroup analysis was performed for periprocedural 
stroke by pooling studies that have utilized >90% EPD 
use and those studies that have not reported any EPD 
utilization rate. Neither of the two subgroups showed any 
significant difference in terms of stroke (EPD not reported; 
OR, 1.65 [0.09–30.97] and EPD >90%; OR, 0.41 [0.05–3.07]) 
(Figure 2).
DISCUSSION
This was a systematic review and meta-analysis of seven 
studies comparing CEA vs CAS for the treatment of carotid 
stenosis associated with radiotherapy for head and neck 
cancer. In a previously published meta-analysis CEA yielded 
a significantly reduced risk of all-cause long-term mortality 
[4]. In the present study, the long-term mortality difference 
between the groups was not detected; this result could 
be attributed to the larger sample size of this study. In ad-
dition, we showed that patients undergoing CEA were at 
an increased risk for periprocedural CN injuries. However, 
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the incidence of periprocedural adverse events including 
stroke, myocardial infarction and short-term all-cause 
mortality were similar between the two groups. Addition-
ally, our results demonstrated no differences in terms of 
late restenosis over an average follow up of 40.5 months 
between the two groups. 
Medical advancements including the use of radiother-
apy, chemotherapy, and surgery have led to increased 
survival rates in patients with head and neck malignan-
cies. This increased survival has inevitably raised the 
overall incidence of post-radiation carotid artery stenosis 
which has been estimated to be 2%–22% [23, 26–28]. 
The development of radiation-induced arterial stenosis 
has been associated with several different pathogenic 
mechanisms, including injury and occlusion of the vasa 
vasorum feeding the arterial wall [29, 30], and endothelial 
cell dysfunction resulting from the effects of ionizing 
radiation itself [31–33]. Indeed, previous clinical studies 
have shown that radiation is an independent risk factor 
for the development of early atherosclerosis [34, 35]. This 
high-risk patient population often requires carotid revas-
cularization for the prevention of neurologic sequelae, 
commonly with CEA or CAS. Intervention is challenging, 
since radiation-induced carotid lesions begin as fibrotic 
changes within the arterial wall, which convert into 
more unstable large necrotic lesions over time [19, 32]. 
This transformation makes them more prone to em-
bolization [36]. Moreover, post-radiation lesions tend 
to affect more extensive segments of carotid arteries 
and have multifocal distribution compared to common 
atherosclerotic lesions; therefore, surgery in irradiated 
anatomy increases the difficulty of the procedure [37, 
38]. Nonetheless, as comparative studies for the treat-
ment of radiation induced carotid artery are sparse, the 
optimal revascularization approach for this entity is still 
under investigation.
Figure 7. Comparison of late restenosis 
between carotid endarterectomy (CEA) and 
carotid artery stenting (CAS)
Figure 6. Comparison of late all-cause mortality 
between carotid endarterectomy (CEA) and 
carotid artery stenting (CAS)
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Recent progress in the field of endovascular man-
agement of carotid stenosis have introduced novel sec-
ond-generation carotid stents which yielded promising 
results in preventing distal embolization during CAS (“the 
cheese-grater effect” with older stents) [39, 40]. Addition-
ally, current evidence suggests that dual layer embolic 
prevention stent systems have shown to be safe and 
effective in reducing stroke risk due to intraprocedural 
debris dislodgement from the target lesion and during the 
post-CAS period [40, 41]. However, the use of EPD can be 
affected by the operator experience and it has been related 
with certain complications during deployment or retrieval 
processes in cases of difficult anatomy and unstable ulcer-
ative plaques [42]. 
Optimized neuroprotection during CAS with con-
ventional stents may minimize intraprocedural cerebral 
embolism [43], albeit the problem of early or delayed 
postprocedural embolism can be better addressed with 
second generation stents which can maximize plaque 
coverage and prevent prolapse between the stent struts 
[44]. This is a great advantage of dual layer stents, since 
plaque protrusion has been associated with high-risk of 
ischemic complications during the 30-day post-CAS follow 
up period [40]. Moreover, proximal occlusion devices using 
flow arrest or reversal systems shown promising results in 
preventing post-CAS stroke [45]. Interestingly, the use of 
a proximal neuroprotection device in combination with 
new generation mesh stents has been described success-
fully during the endovascular treatment of challenging 
cases [46]. Future prospective studies should evaluate the 
introduction of these novel stents and techniques in the 
treatment of patients with radiation-induced carotid lesions, 
which constitute by definition a high-risk subset of patients. 
Traditionally CEA has been associated with higher 
rates of CN injuries and local wound complications (e.g. 
infection, poor wound healing) [11, 47]. Moreover, there 
is evidence that history of radiotherapy for head and neck 
malignancies may have an additive effect to this higher 
risk for CN deficits owing to fibrotic remodeling in the 
perivascular soft tissue [48]. Our meta-analysis demon-
strated that patients in the CEA group experienced CN 
injuries more frequently than the patients from the CAS 
group. However, previous studies are in agreement with 
the current meta-analysis showing that these cranial nerve 
deficits are rather transient and of low clinical significance 
[11, 49]. Furthermore, as our study did not detect any sig-
nificant differences in the rates of periprocedural stroke, 
death, and MI between the two approaches, it could be 
concluded that both procedures seem to be equally safe 
in terms of periprocedural complications. It should be 
noted, however, that even though statistical significance 
was not reached for periprocedural stroke, its respective 
absolute incidence rates in CEA and CAS were 1.4% and 
3.4%, which can raise the point of low statistical power 
to detect this difference. Future prospective cohorts and 
large registries should be designed to compare the two 
approaches and validate our results.
Despite the non-inferiority of CAS compared to CEA 
in terms of periprocedural adverse events, the former has 
been associated with higher rates of long-term restenosis 
and poor anatomic outcome in patients with radiation 
exposure; however, results are inconclusive in the literature. 
The pooled estimates of our meta-analysis did not show 
any significant differences in the rates of late restenosis 
between the two groups. However, it should be noted 
that the absolute incidence of restenosis in the present 
study was 9.7% and 16.3% in the CEA and CAS groups 
respectively, which raises the concern of low statistical 
power to detect this difference. In accordance with our 
results, a previous systematic review reported a 9.7% and 
18.2% long-term restenosis rate; however this study was 
not a meta-analysis and head to head comparisons were 
not made [50]. Also, a prospective study investigating the 
long-term outcomes of CAS among patients that received 
radiotherapy vs patients being at high risk for surgery but 
without a history of head and neck radiation showed that 
radiation exposure was associated with lower freedom 
from restenosis during a mean follow up of 14.4 months; 
however a comparison between CEA and CAS was not 
made in that study [14]. In conclusion, current available 
evidence is insufficient to draw conclusions and thus, 
prospective studies with standardized follow-up intervals 
are warranted to investigate and compare restenosis rates 
in the two groups. 
Limitations
This study was a systematic review and meta-analysis of 
comparative observational studies. However, there are 
several limitations that should be acknowledged. EPD use 
was not consistently reported by all studies and for this 
reason we conducted a subgroup analysis of stroke based 
on EPD reporting, which showed no differences. Impor-
tantly, however, future studies should always report the use 
of EPD during CAS as this is considered standard of care 
and is important information to the reader. Moreover, data 
regarding radiation dose regimen were inconsistently re-
ported and varied widely among the included studies. The 
dose of external neck irradiation can affect the severity and 
extent of radiation-induced vasculopathy and lack of this 
information might have affected our outcomes. Further-
more, as patient-level data was not available, adjusted OR 
utilizing patients’ comorbidities and procedural character-
istics could not be provided. Additionally, data regarding 
the anti-platelet therapy and statin prescription during 
follow up were sparse. Furthermore, the data in each treat-
ment arm regarding specific outcomes for symptomatic or 
asymptomatic carotid disease were inconsistently report-
ed. Lastly, the follow-up intervals were not standardized 
across the included studies and a consistent definition for 
restenosis was not provided. 
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CONCLUSIONS
This meta-analysis demonstrated that CEA is associated 
with higher periprocedural CN injuries compared to CAS, 
although the periprocedural death, stroke and MI rates 
were not different between the two groups. Additionally, 
no significant differences were detected in terms of late 
all-cause mortality and restenosis between CEA and CAS. 
Further prospective studies are needed in order to elimi-
nate bias and identify the optimal therapeutic approach 
for radiation-induced carotid stenosis.
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